ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ACET Adicet Bio Inc

1.35
-0.10 (-6.90%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Adicet Bio Inc NASDAQ:ACET NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -6.90% 1.35 1.33 1.37 1.48 1.34 1.46 495,902 05:00:00

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference

07/05/2024 12:00pm

Business Wire


Adicet Bio (NASDAQ:ACET)
Historical Stock Chart


From Apr 2024 to Jun 2024

Click Here for more Adicet Bio Charts.

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the 2024 Citizens JMP Life Sciences Conference being held from May 13-14, 2024 in New York.

Details of the event are as follows: Date: Tuesday, May 14, 2024 Time: 1:30 p.m. ET

The live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at http://www.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. For more information, please visit our website at https://www.adicetbio.com.

Adicet Bio., Inc. Investor and Media Contacts

Anne Bowdidge abowdidge@adicetbio.com

Janhavi Mohite Stern Investor Relations, Inc. 212-362-1200 janhavi.mohite@sternir.com

1 Year Adicet Bio Chart

1 Year Adicet Bio Chart

1 Month Adicet Bio Chart

1 Month Adicet Bio Chart

Your Recent History

Delayed Upgrade Clock